4 completed, 2 recruiting, 2 unknown, 1 terminated. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Trisomy: new trials by email Literature Review of Trisomy trials Research Report on Trisomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13 DA Scaling Strategies - Decision Aid | Not applicable | Completed | CHU de Quebec-Universite Laval | 887 | 2023-02-01 | 2024-10-18 |
| Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY) no intervention - Sex Chromosome Aneuploidy | Recruiting | University of Colorado, Denver | 5000 | 2022-04-28 | 2024-04-18 | |
| Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction Blood samples - Fetal Growth Retardation | Unknown | University Hospital, Bordeaux | 300 | 2021-10-05 | 2023-11-08 | |
| Automated Screen for Fetal Aneuploidy blood test - Trisomy 21 and Other Fetal Aneuploidy | Unknown | BioCeryx | 2000 | 2017-07-15 | 2018-08-17 | |
| Non-Invasive Chromosomal Evaluation of Trisomy Study Aneuploidy, Trisomy 21 | Completed | Cindy Cisneros | 2000 | 2014-04-01 | 2020-04-30 | |
| Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies Down Syndrome, Fetal Aneuploidy | Completed | Sequenom, Inc. | 3062 | 2012-03-01 | 2016-04-20 | |
| Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial Blood Draw - Trisomy 13, Trisomy 18 | Terminated | Natera, Inc. | 937 | 2012-01-01 | 2023-03-23 | |
| Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy Down Syndrome, Fetal Aneuploidy | Recruiting | Sequenom, Inc. | 2000 | 2011-05-01 | 2026-09-09 | |
| Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies Maternal blood draw of 30 to 50ml - Down Syndrome, Aneuploidy | Completed | Sequenom, Inc. | 150 | 2009-11-01 | 2021-09-20 |
Down Syndrome (6) · Aneuploidy (4) · Trisomy 13 Syndrome (2) · Trisomy 18 Syndrome (2) · Chromosome Disorders (1) · Fetal Growth Retardation (1) · Klinefelter Syndrome (1) · Tetrasomy (1) · Turner Syndrome (1)
Chromosome Aberrations (9) · Chromosome Duplication (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Congenital Abnormalities (7) · Genetic Diseases, Inborn (7) · Abnormalities, Multiple (6) · Chromosome Disorders (6) · Intellectual Disability (6) · Nervous System Diseases (6) · Neurobehavioral Manifestations (6) · Neurologic Manifestations (6) · Aneuploidy (5) · Female Urogenital Diseases and Pregnancy Complications (3)
Blood Specimen Collection (2) · Hematologic Tests (1)
Sequenom, Inc. (3) · BioCeryx (1) · CHU de Quebec-Universite Laval (1) · Cindy Cisneros (1) · Natera, Inc. (1) · University Hospital, Bordeaux (1) · University of Colorado, Denver (1)
United States (6) · Canada (5) · Spain (2) · Australia (1) · Belgium (1) · France (1) · Ireland (1) · Italy (1) · Portugal (1) · South Korea (1) · United Kingdom (1)
Daniel Grosu, MD (1) · Juan-Sebastian Saldivar, M.D. (1) · Juan-Sebastian Saldivar, MD (1) · Ronald Wapner, MD (1) · Shanlee M Davis, MD, PhD (1) · Thomas J Musci, MD (1)
R44HD062114 (1)